| Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt‐induced hypertension Y Li, M Shen, D Ferens, BRS Broughton, P Murthi, S Saini, RE Widdop, ... British Journal of Pharmacology 178 (5), 1164-1181, 2021 | 12 | 2021 |
| Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice Y Li, A Chakraborty, BRS Broughton, D Ferens, RE Widdop, SD Ricardo, ... Biomedicine & Pharmacotherapy 144, 112256, 2021 | 8 | 2021 |
| Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease Y Li, S Ricardo, C Samuel Int. J. Mol. Sci 23 (11), 2022 | 6 | 2022 |
| Simultaneous late-gadolinium enhancement and T1 mapping of fibrosis and a novel cell-based combination therapy in hypertensive mice Y Li, G Zheng, E Salimova, BRS Broughton, SD Ricardo, M de Veer, ... Biomedicine & Pharmacotherapy 158, 114069, 2023 | 3 | 2023 |
| Bone Marrow-derived Mesenchymal Stromal Cells Engineered To Release Anti-fibrotic Cargo, Evoke Renoprotective Effects Against Hypertensive Chronic Kidney Disease Y Li, BR Broughton, DM Ferens, RE Widdop, S Ricardo, C Samuel Hypertension 79 (Suppl_1), A062-A062, 2022 | | 2022 |
| Simultaneous late-gadolinium enhancement and T1 mapping to detect diffuse myocardial fibrosis in 1K/DOCA/salt-induced mice using MP2RAGE G Zheng, Y Li, E Salimova, HX Wang, S Zhong, CS Samuel, M de Veer, ... | | |
